41 results about "Vasomotor" patented technology

Soymilk is provided which can prevent or alleviate menopausal disorders, and is highly safe with no risk of side effects even with long-term intake thereof. This soymilk is made from germinated soybeans, and is used for alleviating or preventing the vasomotor disorder-like symptoms and psychoneuropathic disorder-like symptoms associated with menopausal disorders. Furthermore, this soymilk is labeled with a notice specifying that the soymilk is to be used for alleviating or preventing the vasomotor disorder-like symptoms and psychoneuropathic disorder-like symptoms of menopausal disorders.

The invention provides compounds of the Formula:

that are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as pre-menstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa, bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.

The invention relates to the technical field of body building and weight losing and in particular relates to an ice hot body building and weight losing method and equipment suitable for the same. The ice hot body building and weight losing method comprises the following specific step: simultaneously carrying out thermal stimulation and cold stimulation to two positions of a human body. The equipment suitable for the method comprises a tank body and a tank cover, wherein the lower part of the interior of the tank body is provided with a cold water tank; the upper part of the interior of the tank body is provided with a hot air chamber; and the cold water tank is communicated with the hot air chamber. When the cold water tank carries out cold stimulation on certain position of the human body, vessels of the whole body participate in vasomotor motion to increase the elasticity of the vessels, thereby bringing convenience for preventing and treating arteriosclerosis, hypertension and coronary heart disease, and performing the action on building the body. In addition, the human body is stimulated to quicken metabolism to resist freezing so as to improve the fat consumption rate of the human body; the hot air chamber is used for carrying out thermal stimulation on other positions of the human body; and the thermal environment is utilized to quicken the human body to perspire and quicken the fat to burn so as to finally realize the purpose of losing weight.

Compounds of the formula

useful for the treatment of diseases such as depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder (including trichotillomania), social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa, bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.

Compounds of the formula

useful for the treatment of such as depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as premenstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder (including trichotillomania), social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa, bulimia nervosa, vasomotor flushing, cocaine and alcohol addition, sexual dysfunction (including premature ejaculation), and related illnesses.

The present application describes compounds according to Formula I, wherein Q, R¹, R² and X are described herein, that are useful as Estrogen Receptor Beta (ERβ) modulators. Additionally, the present application describes pharmaceutical compositions containing the compounds according to Formula I and optionally additional therapeutic agents. Finally, the present application describes methods utilizing the compounds according to Formula I for modulating the function of ERβ in the treatment of diseases and disorders associated with ERβ such as, for example, bone disorders; cardiovascular diseases; hypercholesterolemia; hypertriglyceridemia; vasomotor disorders; urogenital disorders; prostatic hypertrophy; endometrial hyperplasia; cancer and central nervous system disorders, such as, neurodegenerative disorders.